Selina Rajan1,2, Martin McKee1, Sumathy Rangarajan2, Shrikant Bangdiwala2, Annika Rosengren3, Rajeev Gupta4, Vellappillil Raman Kutty5, Andreas Wielgosz6, Scott Lear7, Khalid F AlHabib8, Homer U Co9, Patricio Lopez-Jaramillo10, Alvaro Avezum11, Pamela Seron12, Aytekin Oguz13, Iolanthé M Kruger14, Rafael Diaz15, Mat-Nasir Nafiza16, Jephat Chifamba17, Karen Yeates18, Roya Kelishadi19, Wadeia Mohammed Sharief20, Andrzej Szuba21, Rasha Khatib22,23, Omar Rahman24, Romaina Iqbal25, Hu Bo26, Zhu Yibing26, Li Wei26, Salim Yusuf2. 1. Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, Tavistock Place, London, United Kingdom. 2. Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada. 3. Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Sweden. 4. Eternal Heart Care Centre & Research Institute, Jaipur, India. 5. Health Action by People, Trivandrum, India. 6. Department of Medicine, University of Ottawa, Ontario, Canada. 7. Faculty of Health Sciences, Simon Fraser University, Burnaby, Division of Cardiology, Providence Health Care, Vancouver, British Columbia, Canada. 8. Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia. 9. University of the Philippines College of Medicine, Manila, Philippines. 10. Masira Research Institute, Medical School, Universidad de Santander (UDES), FOSCAL, Bucaramanga, Colombia. 11. Department of Medicine, Universidade de Santo Amaro, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil. 12. Universidad de La Frontera, Temuco, Chile. 13. Istanbul Medeniyet University, Faculty of Medicine, Department of Internal Medicine, Istanbul, Turkey. 14. Africa Unit for Transdisciplinary Health Research, North-West University, Potchefstroom, South Africa. 15. Estudios Clínicos Latinoamérica (ECLA), Rosario, Santa Fe, Argentina. 16. Faculty of Medicine, UiTM, Malaysia. 17. University of Zimbabwe College of Health Sciences, Department of Physiology, Harare, Zimbabwe. 18. Department of Medicine, Queen's University, Kingston, Ontario, Canada. 19. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. 20. Department of Medicine, Dubai Medical University, Hatta Hospital, Dubai Health Authority, Dubai, United Arab Emirates. 21. Department of Angiology, Wroclaw Medical University, Poland. 22. Advocate Research Institute, Advocate Health Care, Downers Grove, Illinois. 23. Institute for Community and Public Health, Birzeit University, Birzeit, Palestine. 24. Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan. 25. Independent University, Bangladesh, Dhaka, Bangladesh. 26. National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Abstract
Importance: Depression is associated with incidence of and premature death from cardiovascular disease (CVD) and cancer in high-income countries, but it is not known whether this is true in low- and middle-income countries and in urban areas, where most people with depression now live. Objective: To identify any associations between depressive symptoms and incident CVD and all-cause mortality in countries at different levels of economic development and in urban and rural areas. Design, Setting, and Participants: This multicenter, population-based cohort study was conducted between January 2005 and June 2019 (median follow-up, 9.3 years) and included 370 urban and 314 rural communities from 21 economically diverse countries on 5 continents. Eligible participants aged 35 to 70 years were enrolled. Analysis began February 2018 and ended September 2019. Exposures: Four or more self-reported depressive symptoms from the Short-Form Composite International Diagnostic Interview. Main Outcomes and Measures: Incident CVD, all-cause mortality, and a combined measure of either incident CVD or all-cause mortality. Results: Of 145 862 participants, 61 235 (58%) were male and the mean (SD) age was 50.05 (9.7) years. Of those, 15 983 (11%) reported 4 or more depressive symptoms at baseline. Depression was associated with incident CVD (hazard ratio [HR], 1.14; 95% CI, 1.05-1.24), all-cause mortality (HR, 1.17; 95% CI, 1.11-1.25), the combined CVD/mortality outcome (HR, 1.18; 95% CI, 1.11-1.24), myocardial infarction (HR, 1.23; 95% CI, 1.10-1.37), and noncardiovascular death (HR, 1.21; 95% CI, 1.13-1.31) in multivariable models. The risk of the combined outcome increased progressively with number of symptoms, being highest in those with 7 symptoms (HR, 1.24; 95% CI, 1.12-1.37) and lowest with 1 symptom (HR, 1.05; 95% CI, 0.92 -1.19; P for trend < .001). The associations between having 4 or more depressive symptoms and the combined outcome were similar in 7 different geographical regions and in countries at all economic levels but were stronger in urban (HR, 1.23; 95% CI, 1.13-1.34) compared with rural (HR, 1.10; 95% CI, 1.02-1.19) communities (P for interaction = .001) and in men (HR, 1.27; 95% CI, 1.13-1.38) compared with women (HR, 1.14; 95% CI, 1.06-1.23; P for interaction < .001). Conclusions and Relevance: In this large, population-based cohort study, adults with depressive symptoms were associated with having increased risk of incident CVD and mortality in economically diverse settings, especially in urban areas. Improving understanding and awareness of these physical health risks should be prioritized as part of a comprehensive strategy to reduce the burden of noncommunicable diseases worldwide.
Importance: Depression is associated with incidence of and premature death from cardiovascular disease (CVD) and cancer in high-income countries, but it is not known whether this is true in low- and middle-income countries and in urban areas, where most people with depression now live. Objective: To identify any associations between depressive symptoms and incident CVD and all-cause mortality in countries at different levels of economic development and in urban and rural areas. Design, Setting, and Participants: This multicenter, population-based cohort study was conducted between January 2005 and June 2019 (median follow-up, 9.3 years) and included 370 urban and 314 rural communities from 21 economically diverse countries on 5 continents. Eligible participants aged 35 to 70 years were enrolled. Analysis began February 2018 and ended September 2019. Exposures: Four or more self-reported depressive symptoms from the Short-Form Composite International Diagnostic Interview. Main Outcomes and Measures: Incident CVD, all-cause mortality, and a combined measure of either incident CVD or all-cause mortality. Results: Of 145 862 participants, 61 235 (58%) were male and the mean (SD) age was 50.05 (9.7) years. Of those, 15 983 (11%) reported 4 or more depressive symptoms at baseline. Depression was associated with incident CVD (hazard ratio [HR], 1.14; 95% CI, 1.05-1.24), all-cause mortality (HR, 1.17; 95% CI, 1.11-1.25), the combined CVD/mortality outcome (HR, 1.18; 95% CI, 1.11-1.24), myocardial infarction (HR, 1.23; 95% CI, 1.10-1.37), and noncardiovascular death (HR, 1.21; 95% CI, 1.13-1.31) in multivariable models. The risk of the combined outcome increased progressively with number of symptoms, being highest in those with 7 symptoms (HR, 1.24; 95% CI, 1.12-1.37) and lowest with 1 symptom (HR, 1.05; 95% CI, 0.92 -1.19; P for trend < .001). The associations between having 4 or more depressive symptoms and the combined outcome were similar in 7 different geographical regions and in countries at all economic levels but were stronger in urban (HR, 1.23; 95% CI, 1.13-1.34) compared with rural (HR, 1.10; 95% CI, 1.02-1.19) communities (P for interaction = .001) and in men (HR, 1.27; 95% CI, 1.13-1.38) compared with women (HR, 1.14; 95% CI, 1.06-1.23; P for interaction < .001). Conclusions and Relevance: In this large, population-based cohort study, adults with depressive symptoms were associated with having increased risk of incident CVD and mortality in economically diverse settings, especially in urban areas. Improving understanding and awareness of these physical health risks should be prioritized as part of a comprehensive strategy to reduce the burden of noncommunicable diseases worldwide.
Authors: Pim Cuijpers; Nicole Vogelzangs; Jos Twisk; Annet Kleiboer; Juan Li; Brenda W Penninx Journal: J Affect Disord Date: 2014-03-15 Impact factor: 4.839
Authors: Vikram Patel; Shekhar Saxena; Crick Lund; Graham Thornicroft; Florence Baingana; Paul Bolton; Dan Chisholm; Pamela Y Collins; Janice L Cooper; Julian Eaton; Helen Herrman; Mohammad M Herzallah; Yueqin Huang; Mark J D Jordans; Arthur Kleinman; Maria Elena Medina-Mora; Ellen Morgan; Unaiza Niaz; Olayinka Omigbodun; Martin Prince; Atif Rahman; Benedetto Saraceno; Bidyut K Sarkar; Mary De Silva; Ilina Singh; Dan J Stein; Charlene Sunkel; JÜrgen UnÜtzer Journal: Lancet Date: 2018-10-09 Impact factor: 79.321
Authors: Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs Journal: World Psychiatry Date: 2017-06 Impact factor: 49.548
Authors: Wayne J Katon; Elizabeth H B Lin; Michael Von Korff; Paul Ciechanowski; Evette J Ludman; Bessie Young; Do Peterson; Carolyn M Rutter; Mary McGregor; David McCulloch Journal: N Engl J Med Date: 2010-12-30 Impact factor: 91.245
Authors: Crick Lund; Mark Tomlinson; Mary De Silva; Abebaw Fekadu; Rahul Shidhaye; Mark Jordans; Inge Petersen; Arvin Bhana; Fred Kigozi; Martin Prince; Graham Thornicroft; Charlotte Hanlon; Ritsuko Kakuma; David McDaid; Shekhar Saxena; Dan Chisholm; Shoba Raja; Sarah Kippen-Wood; Simone Honikman; Lara Fairall; Vikram Patel Journal: PLoS Med Date: 2012-12-27 Impact factor: 11.069
Authors: Hillary L Ditmars; Mark W Logue; Rosemary Toomey; Ruth E McKenzie; Carol E Franz; Matthew S Panizzon; Chandra A Reynolds; Kristy N Cuthbert; Richard Vandiver; Daniel E Gustavson; Graham M L Eglit; Jeremy A Elman; Mark Sanderson-Cimino; McKenna E Williams; Ole A Andreassen; Anders M Dale; Lisa T Eyler; Christine Fennema-Notestine; Nathan A Gillespie; Richard L Hauger; Amy J Jak; Michael C Neale; Xin M Tu; Nathan Whitsel; Hong Xian; William S Kremen; Michael J Lyons Journal: Psychol Med Date: 2021-01-12 Impact factor: 10.592
Authors: Ailiana Santosa; Annika Rosengren; Chinthanie Ramasundarahettige; Sumathy Rangarajan; Sadi Gulec; Jephat Chifamba; Scott A Lear; Paul Poirier; Karen E Yeates; Rita Yusuf; Andreas Orlandini; Liu Weida; Li Sidong; Zhu Yibing; Viswanathan Mohan; Manmeet Kaur; Katarzyna Zatonska; Noorhassim Ismail; Patricio Lopez-Jaramillo; Romaina Iqbal; Lia M Palileo-Villanueva; Afzalhusein H Yusufali; Khalid F AlHabib; Salim Yusuf Journal: JAMA Netw Open Date: 2021-12-01
Authors: Sandra Martín-Peláez; Lluis Serra-Majem; Naomi Cano-Ibáñez; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Dolores Corella; Camille Lassale; Jose Alfredo Martínez; Ángel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramón Estruch; Francisco J Tinahones; José Lapetra; Fernando Fernández-Aranda; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía; Josep Vidal; Clotilde Vázquez; Lidia Daimiel; Emili Ros; Estefanía Toledo; Stephanie K Nishi; Jose V Sorli; Mireia Malcampo; M Ángeles Zulet; Anaí Moreno-Rodríguez; Raquel Cueto-Galán; Diego Vivancos-Aparicio; Antoni Colom; Antonio García-Ríos; Rosa Casas; M Rosa Bernal-López; Jose Manuel Santos-Lozano; Zenaida Vázquez; Carlos Gómez-Martínez; Carolina Ortega-Azorín; Jose Luís Del Val; Itziar Abete; Amaia Goikoetxea-Bahon; Elena Pascual; Nerea Becerra-Tomás; Juan J Chillarón; Almudena Sánchez-Villegas Journal: PLoS One Date: 2022-04-13 Impact factor: 3.240
Authors: Jean-Pierre Després; André C Carpentier; André Tchernof; Ian J Neeland; Paul Poirier Journal: J Am Coll Cardiol Date: 2021-08-03 Impact factor: 27.203